Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants

Authors

Institutions

Publication Details

Journal
Drugs in R&D
Published
2024-10-05
DOI
https://doi.org/10.1007/s40268-024-00490-6
Citations
1
Primary Topic
Toxin Mechanisms and Immunotoxins
Type
article
Field-Weighted Citation Impact
0.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants

Tonke Van Bragt, Jan Noukens, Shan Jing, Pu Xia et al.
1 citations
Drugs in R&D
Toxin Mechanisms and Immunotoxins
0.24
article

Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants

Tonke Van Bragt, Jan Noukens, Shan Jing, Pu Xia, Harald H. Reinhart, Lina Wang, Xiaowen Gu, Jiajia Chen, Yu Zhang, Yang Lin, Antonio Guglietta, Jing Liu
article en
1 citations

Abstract

No abstract available for this paper.
Drugs in R&DVol. 24(4)
Capital Medical University (CN), Thales (Netherlands) (NL), Zapata (United States) (US), Beijing Anzhen Hospital (CN), Wuhan Union Hospital (CN), Argenx (Belgium) (BE)
Zero hunger
Openalex Percentile: Top 42%
Toxin Mechanisms and Immunotoxins
0.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants — Tonke Van Bragt, Jan Noukens, et al. · Drugs in R&D (2024) | TGRS Research Map | TGRS